| scholarly article | Q13442814 |
| P2093 | author name string | W. Jiang | |
| J. M. Becker | |||
| Y. Koltin | |||
| L. K. Henry | |||
| P2860 | cites work | Phosphatidylcholine translocase: a physiological role for the mdr2 gene | Q24319732 |
| Allelism of SNQ1 and ATR1, genes of the yeast Saccharomyces cerevisiae required for controlling sensitivity to 4-nitroquinoline-N-oxide and aminotriazole. | Q27934249 | ||
| A positive selection for mutants lacking orotidine-5'-phosphate decarboxylase activity in yeast: 5-fluoro-orotic acid resistance | Q28131606 | ||
| ABC Transporters: From Microorganisms to Man | Q28181688 | ||
| Flip-flop: the transmembrane translocation of lipids | Q28240262 | ||
| A major superfamily of transmembrane facilitators that catalyse uniport, symport and antiport | Q28266457 | ||
| Biochemistry of multidrug resistance mediated by the multidrug transporter | Q29616476 | ||
| Analysis of a Candida albicans gene that encodes a novel mechanism for resistance to benomyl and methotrexate | Q33630438 | ||
| Candida albicans gene encoding resistance to benomyl and methotrexate is a multidrug resistance gene | Q33752151 | ||
| Isogenic strain construction and gene mapping in Candida albicans. | Q33961115 | ||
| Disruption of the mouse mdr1a P-glycoprotein gene leads to a deficiency in the blood-brain barrier and to increased sensitivity to drugs | Q34059522 | ||
| Functional expression of P-glycoprotein encoded by the mouse mdr3 gene in yeast cells | Q36715176 | ||
| ATR1, a Saccharomyces cerevisiae gene encoding a transmembrane protein required for aminotriazole resistance | Q36782973 | ||
| Functional expression of human mdr1 in the yeast Saccharomyces cerevisiae | Q36893950 | ||
| Pathogenicity of Candida albicans auxotrophic mutants in experimental infections. | Q36968724 | ||
| Multidrug resistance in Candida albicans: disruption of the BENr gene | Q39779132 | ||
| ATP-dependent transport systems in bacteria and humans: relevance to cystic fibrosis and multidrug resistance | Q40384605 | ||
| Genetics and biochemistry of yeast multidrug resistance | Q40696620 | ||
| The role of cell-mediated immunity in candidiasis | Q40704101 | ||
| Clinical trials of agents that reverse multidrug resistance. A literature review | Q40786414 | ||
| How many yeast genes code for membrane-spanning proteins? | Q40844123 | ||
| Resistance of yeasts to azole-derivative antifungals | Q40918799 | ||
| PDR5, a novel yeast multidrug resistance conferring transporter controlled by the transcription regulator PDR1. | Q48085649 | ||
| Functional complementation of yeast ste6 by a mammalian multidrug resistance mdr gene | Q54272057 | ||
| The emerging fungal threat | Q72124266 | ||
| P433 | issue | 11 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | Candida albicans | Q310443 |
| multiple drug resistance | Q643839 | ||
| P304 | page(s) | 4515-4518 | |
| P577 | publication date | 1995-11-01 | |
| P1433 | published in | Infection and Immunity | Q6029193 |
| P1476 | title | Reduced virulence of Candida albicans mutants affected in multidrug resistance | |
| P478 | volume | 63 |
| Q47165005 | A New Determinant of Candida glabrata Virulence: The Acetate Exporter CgDtr1. |
| Q39573569 | Altered expression of selectable marker URA3 in gene-disrupted Candida albicans strains complicates interpretation of virulence studies |
| Q40878512 | Antifungal resistance trends towards the year 2000. Implications for therapy and new approaches |
| Q35105859 | Candida albicans septin mutants are defective for invasive growth and virulence |
| Q33721804 | Clinical, cellular, and molecular factors that contribute to antifungal drug resistance. |
| Q35124771 | Comparative resistance of Candida albicans clinical isolates to fluconazole and itraconazole in vitro and in vivo in a murine model. |
| Q37545098 | Distinct roles of Candida albicans drug resistance transcription factors TAC1, MRR1, and UPC2 in virulence |
| Q37226653 | Ectopic expression of URA3 can influence the virulence phenotypes and proteome of Candida albicans but can be overcome by targeted reintegration of URA3 at the RPS10 locus |
| Q33979398 | Enhanced extracellular production of aspartyl proteinase, a virulence factor, by Candida albicans isolates following growth in subinhibitory concentrations of fluconazole |
| Q52689083 | Enhanced phenolic compounds tolerance response of Clostridium beijerinckii NCIMB 8052 by inactivation of Cbei_3304. |
| Q33979724 | Experimental induction of fluconazole resistance in Candida tropicalis ATCC 750 |
| Q33701518 | Fluconazole versus Candida albicans: a complex relationship. |
| Q39746465 | Functional Similarities and Differences between Candida albicans Cdr1p and Cdr2p Transporters |
| Q35125420 | Fungal virulence genes as targets for antifungal chemotherapy. |
| Q90028212 | Host-Pathogen Interactions Mediated by MDR Transporters in Fungi: As Pleiotropic as it Gets! |
| Q34108708 | Impact of multidrug-resistant Pseudomonas aeruginosa bacteremia on patient outcomes. |
| Q28547078 | Inhibitors of the Candida albicans Major Facilitator Superfamily Transporter Mdr1p Responsible for Fluconazole Resistance |
| Q33389525 | MFS transportome of the human pathogenic yeast Candida albicans |
| Q34438173 | Pathway analysis of Candida albicans survival and virulence determinants in a murine infection model |
| Q36672016 | Proton-dependent multidrug efflux systems |
| Q46345548 | Relationship between susceptibility of Candida spp. isolates to amphotericin B and death or survival of patients with candidemia episodes |
| Q34334162 | Role of AFR1, an ABC transporter-encoding gene, in the in vivo response to fluconazole and virulence of Cryptococcus neoformans |
| Q28834633 | Xenobiotic efflux in bacteria and fungi: a genomics update |
Search more.